The Roles of Dietary PPARγ Ligands for Metastasis in Colorectal Cancer

被引:26
作者
Kuniyasu, Hiroki [1 ]
机构
[1] Nara Med Univ, Dept Mol Pathol, Sch Med, Nara 6348521, Japan
关键词
D O I
10.1155/2008/529720
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Dietary peroxisome proliferator-activated receptor (PPAR)gamma ligands, linoleic acid (LA) and conjugated linoleic acid (CLA), showed anticancer effects in colorectal carcinoma cells. LA is metabolized by two pathways. Cyclooxygenase (COX)-2 produces procarcinogenic prostaglandin E2, whereas 15-lipoxygenase (LOX)-1 produces PPAR gamma ligands. The 15LOX-1 pathway, which is dominant in colorectal adenomas, was downregulated and inversely COX-2 was upregulated in colorectal cancer. LA and CLA inhibited peritoneal metastasis of colorectal cancer cells in nude mice. The inhibitory effect was abrogated by PPAR gamma antisense treatment. A continuous LA treatment provided cancer cells quiescence. These quiescent cells formed dormant nests in nude mice administrated LA. The quiescent and dormant cells showed downregulated PPAR gamma and upregulated nucleostemin. Thus, short-term exposure to dietary PPAR gamma ligands inhibits cancer metastasis, whereas consistent exposure to LA provides quiescent/dormant status with possible induction of cancer stem and/or progenitor phenotype. The complicated roles of dietary PPAR gamma ligands are needed to examine further. Copyright (C) 2008 Hiroki Kuniyasu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
引用
收藏
页数:7
相关论文
共 71 条
[11]   Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells [J].
Deguchi, A ;
Xing, SW ;
Shureiqi, I ;
Yang, PY ;
Newman, RA ;
Lippman, SM ;
Feinmark, SJ ;
Oehlen, B ;
Weinstein, IB .
CANCER RESEARCH, 2005, 65 (18) :8442-8447
[12]   Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor γ (BPARγ) heterodimer:: A basis for new therapeutic strategies [J].
Desreumaux, P ;
Dubuquoy, L ;
Nutten, S ;
Peuchmaur, M ;
Englaro, W ;
Schoonjans, K ;
Derijard, B ;
Desvergne, B ;
Wahli, W ;
Chambon, P ;
Leibowitz, MD ;
Colombel, JF ;
Auwerx, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (07) :827-838
[13]   Up-regulation of cyclooxygenase-2 by interleukin-1β in colon carcinoma cells [J].
Duque, Javier ;
Diaz-Munoz, Manuel D. ;
Fresno, Manuel ;
Iniguez, Miguel A. .
CELLULAR SIGNALLING, 2006, 18 (08) :1262-1269
[14]  
*ED BOARD, 2005, CANC STAT JAP
[15]  
FIDLER IJ, 1990, CANCER RES, V50, P6130
[16]   The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice [J].
Funk, CD .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1304 (01) :65-84
[17]  
Galusca B, 2004, ANTICANCER RES, V24, P1993
[18]   DIETARY FACTORS AND RISK OF COLON-CANCER [J].
GIOVANNUCCI, E ;
WILLETT, WC ;
STUBBS, A .
ANNALS OF MEDICINE, 1994, 26 (06) :443-452
[19]   Mouse models of PPAR-γ deficiency:: dissecting PPAR-γ's role in metabolic homoeostasis [J].
Gray, SL ;
Nora, ED ;
Vidal-Puig, AJ .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2005, 33 :1053-1058
[20]   Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 [J].
Gupta, RA ;
DuBois, RN .
NATURE REVIEWS CANCER, 2001, 1 (01) :11-21